Treace Medical Concepts, Inc. expected to post a loss of 30 cents a share - Earnings Preview

Treace Medical Concepts

05/08/2026 14:25

Treace Medical Concepts, Inc. TMCI.OQ TMCI.O is expected to  show a fall in quarterly revenue when it reports  results on August 7 for the period ending June 30 2026
The Ponte Vedra Florida-based  company is expected to report a 7.1% decrease in revenue to $44.02 million from $47.39 million a year ago, according to the mean estimate from 5 analysts, based on LSEG data.
​LSEG's mean analyst estimate for Treace Medical Concepts, Inc. is for a loss of 30 cents per share. 
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy," 3 "hold" and 1 "sell" or "strong sell."  
The mean earnings estimate of analysts was unchanged in the last three months. ​
Wall Street's median 12-month price target for Treace Medical Concepts, Inc. is $4.00, about 15.6% below its last closing price of $4.74
Previous quarterly performance (using preferred earnings measure in US dollars). ​
QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE 
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Mar. 31 2026
-0.31
-0.31
-0.28
Beat
9.1
Dec. 31 2026
-0.15
-0.15
-0.15
Met
0
Sep. 30 2025
-0.28
-0.28
-0.26
Beat
7.1​
Jun. 30 2025
-0.29
-0.29
-0.28
Beat
2.9
​​Mar. 31 2025
-0.30
-0.30
-0.25
Beat
17.1
Dec. 31 2024
-0.04
-0.04
-0.01
Beat
74.1​
Sep. 30 2024
-0.27
-0.27
-0.25
Beat
8
Jun. 30 2024
-0.29
-0.29
-0.29
Met
0
This summary was machine generated August 5 at 13:25 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)